Literature DB >> 10439522

Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis.

K C Wong1, P J Kennedy, S Lee.   

Abstract

The clinical features and outcomes of 17 patients with Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) were retrospectively reviewed. There were 11 males and six females with an average age of 61.5 years. Ten patients with SJS (seven males, three females) and seven patients with TEN (four males, three females) were identified. Antibiotics, mainly beta-lactams, were the most common cause of SJS/TEN in this series. The mean skin loss in TEN was 45.7% total body surface area in contrast to the lesser skin loss (< 10%) observed in three patients with SJS. Complications included septicaemia, pneumonia and multi-organ failure, mainly in the TEN group. Two patients died from TEN-related complications and one patient with SJS died from unrelated causes. Ocular involvement and skin pigmentary changes represented the most significant long-term sequelae.

Entities:  

Mesh:

Year:  1999        PMID: 10439522     DOI: 10.1046/j.1440-0960.1999.00342.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  8 in total

Review 1.  Epidemiology and risk factors for drug allergy.

Authors:  Bernard Y-H Thong; Teck-Choon Tan
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

2.  Lamotrigine-induced toxic epidermal necrolysis in a young epileptic.

Authors:  Fayaz A Sofi; Parvaiz A Koul; Showkat A Mufti; G N Dhobi
Journal:  BMJ Case Rep       Date:  2011-06-30

3.  Retrospective analysis of Steven Johnson syndrome and toxic epidermal necrolysis over a period of 5 years from northern Karnataka, India.

Authors:  Kikkeri Narayanasetty Naveen; Varadraj V Pai; Vijetha Rai; Sharatchandra B Athanikar
Journal:  Indian J Pharmacol       Date:  2013 Jan-Feb       Impact factor: 1.200

4.  Retrospective analysis of stevens-johnson syndrome and toxic epidermal necrolysis over a period of 10 years.

Authors:  Abarna Devi Sanmarkan; Tukaram Sori; Devinder Mohan Thappa; T J Jaisankar
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

Review 5.  Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms.

Authors:  Ro-Lan Dao; Shih-Chi Su; Wen-Hung Chung
Journal:  Asia Pac Allergy       Date:  2015-04-29

6.  Toxic epidermal necrolysis: a retrospective analysis of 17 cases from central Tunisia.

Authors:  Chaker Ben Salem; Atef Badreddine; Omar Belajouza; Colandane Belajouza; Najet Ghariani; Hmouda Houssem
Journal:  Pan Afr Med J       Date:  2014-11-11

7.  Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction.

Authors:  Valerio Russo; Theo Klein; Darielle J Lim; Nestor Solis; Yoan Machado; Sho Hiroyasu; Layla Nabai; Yue Shen; Matthew R Zeglinski; Hongyan Zhao; Cameron P Oram; Peter A Lennox; Nancy Van Laeken; Nick J Carr; Richard I Crawford; Claus-Werner Franzke; Christopher M Overall; David J Granville
Journal:  Sci Rep       Date:  2018-06-26       Impact factor: 4.379

8.  An analysis of drug induced Stevens-Johnson syndrome.

Authors:  P P Patel; A M Gandhi; C K Desai; M K Desai; R K Dikshit
Journal:  Indian J Med Res       Date:  2012-12       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.